Hormone Replacement Therapy
(asked on 5th November 2021) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 November 2021 to Questions 65535 and 65536 on Hormone Replacement Therapy, for what reason HRT drugs and products have been affected by supply issues.
This question was answered on 15th November 2021
Supply issues that have affected the availability of hormone replacement therapy (HRT) preparations include manufacturing issues, regulatory issues, problems accessing the raw pharmaceutical ingredient as well as commercial decisions made by some companies to divest these products.